These findings imply that LCW may treat LN through the inhibition of the PI3K/AKT/mTOR signaling pathway, offering a potential strategy for managing fibrosis associated with LN and regulating cellular autophagy processes. The gene discussed is MTOR; the disease is lobular neoplasia.